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The influence of the composition and preparation method on the sol–gel transition temperature (Tsol–gel) and rheological response 
of poloxamer-based formulations was determined. Manual and more complex mechanical stirring were found to provide similar 
results. In addition, a linear dependence of Tsol–gel on the poloxamer content was observed in the range of concentrations analyzed, 
and a Poloxamer 407® concentration of 18% was selected. The addition of hyaluronic acid did not lead to significant changes in the 
Tsol–gel values. In contrast, the addition of microparticles caused a reduction in Tsol–gel without a significant reduction in gel strength, 
and pseudoplastic characteristics were observed, indicating that a thermoreversible gel was obtained with a rheology suitable for 
application in the treatment of burn wounds.
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INTRODUCTION
Burns are very serious traumas. In addition to the physical 
problems related to skin damage (increase in fluid loss, infection, 
hypothermia, scarring, and compromised immunity) that can cause 
extreme pain and death, a large burn will leave the patient with visible 
physical scars and invisible psychological issues.1 
Among the many different medicines used to treat burn wounds, 
some natural products, such as Aloe vera (Aloe vera Linn, synonym: 
Aloe vera barbadensis Mill.), vitamin E, hyaluronic acid, and chi-
tosan, have been gaining increasing interest over the past few years. 
Aloe vera gel extracts have anti-inflammatory activity and promote 
increased levels of hyaluronic acid and dermatan sulphate in gra-
nulation tissue,2 providing wound healing properties that have been 
proven to lead to faster healing of burns and the reestablishment of 
the vascularity of burn tissues.3 Consequently, burn wound healing 
is one of the major applications of Aloe vera gel in many countries.4 
Vitamin E, an intermediary in arachidonic acid and prostaglandin 
metabolism, is also important in the treatment of inflammatory pro-
cesses, including burns, due to its antioxidant capability.5,6 Hyaluronic 
acid is a non-sulphated glycosaminoglycan (GAG) that is widely 
distributed in body tissues.7 This acid is an extracellular matrix 
component of tissue that forms a pericellular coat on the surfaces 
of cells.8 Hyaluronic acid has been receiving increasing attention 
as a material for tissue engineering because it is believed to have a 
supportive effect on progenitor cell development, thus facilitating 
tissue repair.9 Chitosan is a natural linear biopolyaminosaccharide 
obtained through the alkaline deacetylation of chitin, which is the 
second most abundant polysaccharide after cellulose. Properties such 
as mucoadhesion, bioadhesion, biodegradability, low toxicity, good 
biocompatibility, and the ability to form films make it suitable for use 
in biomedicine (for the immobilization of enzymes in living cells) 
and pharmaceutical formulations.10 
A potential vector for the controlled release of drugs such as 
those mentioned above is thermosensitive hydrogels, which undergo 
thermoreversible gelation, behaving as a solution at low temperatures 
and as a gel above a specific temperature known as the solid–gel 
transition temperature (Tsol–gel). These hydrogels have been used for 
many different pharmaceutical applications, including parenteral, 
ophthalmic, rectal, and topical formulations.11,12
Poloxamers, notably Poloxamer 407®, are substances that have 
recently received remarkable attention in the field of thermosensitive 
hydrogels.13 Poloxamer 407® is an amphiphilic synthetic copoly-
mer consisting of a hydrophobic poly(oxypropylene) (POP) block 
between two hydrophilic poly(oxyethylene) (POE) blocks14-17 and 
has a molecular weight of approximately 12,600 Da (70% POE).18 
Due to their amphiphilic nature, poloxamer molecules can readily 
self-assemble to form micelles depending on the concentration and 
temperature. Dehydration of the hydrophobic POP blocks combined 
with hydration of the POE blocks leads to the formation of sphe-
rical micelles, and subsequent packing of the micellar structure 
results in a 3D cubic lattice that constitutes the main structure of 
poloxamer hydrogels.19-21 These hydrogels are characterized by 
the ability to carry a significant amount of a drug. They are also 
biodegradable, non-toxic, and stable, and therefore are suitable for 
use as controlled-release agents.18
Recently, various hydrophilic polymers, for instance water-solu-
ble cellulose derivatives, polyacrylic acid,22 and chitosan,23 have been 
incorporated into poloxamer gels as auxiliary agents for controlled 
drug release and/or improvement of their mucoadhesive capability. In 
these systems, the poloxamer acts as a gelling agent, and chitosan as 
a carrier and bactericidal agent.24 When these hydrogels are used for 
wound treatment applications, the Tsol–gel is recognized as one of the 
most important parameters for in situ gel-forming systems, because 
they must satisfy two basic requirements: i) be free-flowing liquids 
at room temperature to allow spraying onto the injured tissue; and ii) 
easily form in situ gels at skin temperature. These characteristics are 
required to avoid friction of the product with the injured tissue, thus 
reducing the suffering of patients with skin burns. For this reason, 
the ideal Tsol–gel values are in the range from 30-32 °C.25
Literature data indicates that the poloxamer concentrations in 
hydrogel formulations based on binary poloxamer/water mixtures are 
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generally in the range from 16-20%, with a value of approximately 
18% most frequently used. The techniques most commonly employed 
for the determination of the Tsol–gel are rheometry and visual analy-
sis.23,26-29 For formulations with 18% Poloxamer 407®, Tsol–gel values 
between 25 and 32 °C have been obtained using rheological data 
23,27,29-31
 and 28 and 32 °C using visual analysis.27,29,30
For ternary formulations of poloxamer-based hydrogels, stu-
dies show that Tsol–gel is dependent on both the nature of the third 
component and its percentage. For poloxamer/water/polyethylene 
glycol (PEG) hydrogels, Edsman and co-workers (1998) found that, 
compared to a binary poloxamer/water mixture, the Tsol–gel increased 
with 2% PEG and decreased with 5% and 7% PEG. In contrast, for 
poloxamer/water/vancomicyn hydrogels, no change in the Tsol–gel 
was observed with the addition of the third component,32 while for 
poloxamer/water/Carbopol 934, the Tsol–gel decreased monotonically 
with increasing Carbopol 940 concentration.27 For poloxamer-based 
formulations containing chitosan, Ur-rehman et al. reported that the 
use of chitosan caused an increase in the Tsol–gel.31 With respect to the 
use of polymeric microparticles, no data was found in the literature 
regarding the influence of this type of component on the Tsol–gel of 
poloxamer-based formulations. 
In this context, the aim of this study was to determine the influence 
of the formulation composition on the Tsol–gel and rheological response 
of poloxamer-based formulations for burn wound treatment applica-
tions containing hyaluronic acid and polymeric microparticles com-
posed of Aloe vera/chitosan/vitamin E/polysorbate 80. In addition, to 
enable the large-scale production of the optimized formulation, the 
influence of the preparation method on the Tsol–gel was also analyzed. 
MATERIALS AND METHODS
Chemicals
Poloxamer 407® (Pluronic® F127) was purchased from Sigma 
Aldrich (Steinheim, Germany), and hyaluronic acid was obtained 
from Deg (São Paulo, Brazil). Aloe vera in the form of a spray-dried 
powder, 200:1 in maltodextrin, was obtained from Brasquim (Porto 
Alegre, Brazil). Vitamin E oil was supplied by Pharma Nostra (Rio de 
Janeiro, Brazil), polysorbate 80 by Vetec (Rio de Janeiro, Brazil), low 
molecular weight chitosan by Sigma Aldrich (Steinheim, Germany), 
and acetic acid by F Maia (Cotia, Brazil). Ultrapure water (Milli-Q 
Millipore Simplicity 185, Bedford, MA, USA) was used to prepare 
all of the solutions. 
Microparticle preparation
The Aloe vera/chitosan/vitamin E/polysorbate 80 (4/50/36/10 
w/w/w/w) microparticles were prepared as follows: i) chitosan was 
dissolved in acetic acid (1%); ii) Aloe vera, vitamin E, and polysorbate 
80 were added with stirring until total dispersion was achieved; and 
iii) the mixture was dried in a spray drier (Model 190 Buchi) under 
controlled conditions (inlet air temperature: 120 ± 2 °C, outlet air 
temperature: 78 ± 3 °C, aspirator setting: 10, suspension feed flow 
rate: 0.30 L/h, and airflow rate: 500 L/h).
Microparticle characterization
The final chemical composition of the particles was evaluated 
using infrared (IR) spectroscopy. To obtain spectra in the IR region, 
a sample (approximately a 1.5 mg) was triturated together with 150 
mg potassium bromide, and then the mixture was subjected to com-
pression in a hydraulic press using a pressure of 6 X 104 N/cm2 for 
the preparation of the pastilles. All of the spectra were obtained in 
the transmission mode (32 accumulations) with a resolution of 4 cm-1 
over the frequency range from 4000 to 400 cm-1 
Gel preparation
All of the poloxamer solutions used in this study (17.0; 17.5; 18.0; 
18.5; 19.0; 19.5; 20.0; 20.5; and 21.0% w/w) were prepared by dis-
persing the polymer in ultrapure water. Three different methods were 
used for the dispersion of the poloxamer in water: manual stirring, 
mechanical stirring (400 rpm), and high-performance stirring (13,000 
rpm) (T25 Ultra-Turrax®, Ika, Wilmington, USA).The solutions were 
then stored in a refrigerator at 4 ºC for at least 24 h to ensure complete 
dissolution. Microparticles (1.0% w/w) and hyaluronic acid (1.0% 
w/w) were added to the gel with manual stirring until a homogeneous 
dispersion was obtained. 
Gelation temperature measurement
The sol–gel transition temperature (Tsol–gel) for each formulation 
was measured in a rotational rheometer (ARES, T.A. Instruments®, 
New Castle, USA) using a concentric cylinder geometry with a cup 
diameter of 27 mm and a diameter/height ratio of 25 mm/32 mm. 
As proposed by Bonacucina and co-workers,33 the Tsol–gel was defined 
using temperature sweep tests as the temperature at which the loss 
modulus (G’’) was half way between the values of this parameter for 
the solution and the gel. Based on the results of preliminary strain 
sweep tests, a strain amplitude of 0.1% was used for all of tempera-
ture sweep tests to provide adequate torque and linear viscoelastic 
behavior. The temperature sweep tests were performed in the range 
from 5–45 °C at a frequency of 1.0 Hz and a heating rate of 5 °C/
min. Approximately 8 g of sample was used for each test, and at 
least three replicates were measured for each formulation. Frequency 
sweep tests in the range from 0.1–100.0 rad s-1 were also performed 
at 30 and 35 °C for selected samples. 
Statistical analysis
Analysis of variance (ANOVA) was used for the experimental data 
analysis using the software Statistica 7.0 for Windows (Statistica 7.0, 
Statsoft®, Tulsa, USA) and a degree of confidence of 95%. Post-hoc 
comparisons were made using the Tukey HSD test with a degree of 
confidence of 95% (P<0.05).
RESULTS AND DISCUSSION
Characterization of the gels containing microparticles
Note that it was possible to detect all of the components in 
the IR spectrum of the gel containing the microparticles (see the 
Supplementary Material).
I) Poloxamer gels: influence of different preparation methods
Table 1 presents the Tsol–gel values for water/poloxamer gels con-
taining 18% (P18) poloxamer that were obtained using different pre-
paration methods. It can be seen in the table that the values obtained 
using manual and mechanical stirring were not significantly different 
(p<0.05), while the use of the Ultraturrax® reduced the Tsol–gel. This 
result can be attributed to the higher shear stresses in the Ultraturrax®. 
Based on these results, manual stirring was the method selected 
for the preparation of the remaining formulations evaluated in the 
study because of its ease of operation and the fact that it provided 
results similar to those obtained with mechanical stirring, which is one 
of the methods employed in industry. Thus, it should be possible to be 
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readily scale up the optimal formulation for industrial applications.
II) Influence of the composition on the Tsol–gel 
a)  Water/poloxamer formulations 
Figure 1 shows the behavior of G’’ as a function of temperature 
for the sample with a poloxamer concentration of 17.5 % w/w, where 
the abrupt change in the modulus was used to identify the Tsol–gel, 
as described above. Similar behavior was observed for all of the 
poloxamer concentrations tested, except the formulation with 17% 
poloxamer, for which no sol–gel transition was observed in the range 
of tested temperatures (5 to 45 °C). 
The Tsol–gel values obtained for poloxamer concentrations of 17.5, 
18.0, 18.5, 19.0, 19.5, 20.0, 20.5, and 21.0 % w/w (Figure 2) are in 
agreement with previous results reported in the literature29 and confirm 
that theTsol–gel is dependent on the polymer concentration. In the range 
of concentrations studied, the Tsol–gel of the binary water/poloxamer for-
mulations was inversely proportional to the poloxamer concentration, 
with the appropriate Tsol–gel value (32.55 ± 0.09 °C) corresponding to 
the formulation containing 18% Poloxamer 407®. This dependence 
of Tsol–gel on the poloxamer concentration is in agreement with the me-
chanism of gel formation described by Cabana et al.,13 which involves 
the packing of micelles and micelle entanglements. In this regard, 
the absence of the sol–gel transition for a poloxamer concentration 
of 17.0% can probably be attributed to the low concentration of the 
polymer, which prevents micelle formation.
b)  Formulations containing hyaluronic acid and polymeric micro-
particles 
Table 2 shows the values of Tsol–gel for the binary water/poloxamer 
formulation (P18) alone, with added hyaluronic acid, and with added 
hyaluronic acid and polymeric microparticles (P18/HA and P18/HA/
MP). The poloxamer concentration in all three formulations was 18%. 
Both the P18/HA and P18/HA/MP formulations contained 1% w/w 
hyaluronic acid, with P18/HA/MP also containing 1% polymeric 
microparticles. Statistical analyses revealed that the addition of 
hyaluronic acid led to no significant change in the Tsol–gel in relation to 
the binary water/poloxamer formulation, even though it altered the pH 
from 8.0 to 7.5.32 With the addition of the polymeric microparticles, 
however, the pH remained at approximately 7.5, while the Tsol–gel of 
the system was reduced, although it did remain in the acceptable 
range for burn wound treatment. This reduction in the Tsol–gel indicates 
that for the components and concentrations under study, the effect 
of the addition of the polymeric particles is more intense than that 
of the medium acidification. The decrease in Tsol–gel promoted by the 
addition of the polymeric microparticles is possibly related to higher 
packing of the poloxamer micelles caused by the presence of the 
particles and to some level of interaction with the chitosan present 
in the microparticles.13,29,34 Previous studies have shown that due to 
the size of the chains and the high charge density of –NH2, chitosan 
affects poloxamer gelation through its effect on the formation of water 
channels around the PPO block of the poloxamer.31 
Another possibility relates to the fact that chitosan forms com-
plexes with natural polyelectrolyte polyanions, such as carboxyme-
thylcellulose, polyvinyl alcohol, dextran sulfate, hyaluronic acid, 
carboxymethyldextrane, collagen, and xanthan. When hyaluronic 
acid forms a complex with chitosan, it exhibits the same behavior as 
observed during the formation of other complexes based on chitosan. 
Two oppositely charged polyelectrolytes, chitosan (polycation) and 
hyaluronic acid (polyanion), interact to form an insoluble complex. 
Swelling of the hydrogel is influenced mainly by the ionic interactions 
that occur during complex formation. An increase in the density of 
the interactions between the chains induces a decrease in the swelling 
of the hydrogel and also its pH sensitivity, improving the stability 
of the three-dimensional network. In addition, hydrogels formed by 
ionic forces can swell under basic or acidic conditions, which enables 
biomedical applications in various areas, e.g., adhesives and dental 
restorations, controlled-release devices, and biocompatible materials.
III) Rheological behavior of the poloxamer gels containing 
polymeric microparticles
Figure 3 shows the behavior of the dynamic moduli of the three 
formulations listed in Table 2 at 35 ºC. Although the behavior of the 
G’ and G’’ curves is qualitatively similar for the three formulations, the 
crossover between the G’ and G’’ curves is clearly displaced toward 
Table 1. Sol-gel transition temperature (Tsol-gel) of different gel preparations 
using poloxamer at 18% (w/w)
Preparations Tsol-gel (°C)
Manual Stirring 32.62 ± 0.06 a
Mechanical Stirring 33.45 ± 1.25 a
Ultraturrax® 30.84 ± 1.16 b
Each value is expressed as mean ±1 S.D (n=3). Means within a column fol-
lowed by different letters are significantly different (p≤0.05).
Figure 1. Sol-gel transition temperature (Tsol-gel) using 17.5% Poloxamer 407®
Figure 2. Sol-gel transition temperatures (Tsol-gel) for different Poloxamer 
407® concentrations
Table 2. Sol-gel transition temperature (Tsol-gel) for poloxamer formulations
Formulation Tsol-gel (°C)
P18 32.62 ± 0.06 a
P18/HA 32.90 ± 0.31 a
P18/HA/MP 30.25 ± 0.84 b
Each value is expressed as mean ±1 S.D (n=3). Means followed by different 
letters differ significantly according to the Tukey test (p≤0.05).
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higher frequencies for the gel containing microparticles (Figure 
3c), which is in agreement with the reduction in the Tsol–gel of this 
formulation, as discussed above. Additionally, it can be seen in the 
figure that the final G´ values for P18/HA/MP are of the same order 
of magnitude as those for P18/HA, indicating that the addition of the 
microparticles does not significantly affect the strength of the gel. 
Viscosity vs. temperature curves for the three formulations listed 
in Table 2 are shown in Figure 4. It can be seen in the figure that at 
temperatures below the Tsol–gel, the viscosity of the P18/HA/MP sample 
was higher than that of the P18/HA and P18 samples, but remained 
within the acceptable range for spray applications. At temperatures 
above Tsol–gel, the viscosities were quite similar for all three formula-
tions, indicating a low dependence on the temperature, and were two 
orders of magnitude greater than the viscosity values obtained below 
the Tsol–gel. The dependence of the viscosity on the frequency was also 
investigated, because this characteristic is also important with respect 
to the application of these materials. The results are shown in Figure 5. 
It can be seen in the figure that all of the formulations exhibited pseu-
doplastic behavior; the viscosity decreased as the frequency increased. 
Notably, the P18/HA/MP and P18/HA formulations exhibited slightly 
higher pseudoplasticity than the binary formulation, and thus the 
viscosities of the three formulations become similar at high frequen-
cies despite the fact that P18/HA/MP and P18/HA were much more 
viscous at low frequencies. These characteristics are also desirable 
from the point of view of the application of the formulations in burn 
wound treatment. A high viscosity at low frequencies is important 
for avoiding sag after application on the skin. On the other hand, a 
rapid decrease in the viscosity with deformation is advantageous for 
debridement intervention, for which a low viscosity of the gel layer 
is required to lower the suffering of patients during the application 
of a force to remove dead skin.
CONCLUSIONS
The influence of the composition and preparation method on the 
Tsol–gel and rheological response of water/poloxamer-based formula-
tions was evaluated. Manual stirring was the method selected due to 
its ease of operation and the fact that it provides results similar to 
those obtained with mechanical stirring. In the range of concentrations 
analyzed, a linear dependence of the Tsol–gel on the poloxamer content 
was observed, from which an 18% Poloxamer 407® concentration was 
selected considering the required Tsol–gel range for formulations for 
Figure 3. Elastic (G’) and viscous (G”) modulus as a function of the frequency 
(rad/s) at 35°C for formulations containing: (a) 18% poloxamer; (b) 18% 
poloxamer + 1% hyaluronic acid, and;(c) 18% poloxamer + 1% hyaluronic 
acid + 1% microparticles
Figure 4. Viscosity vs. temperature curves for the three formulations listed 
in Table 2 at 1 rad/s
Figure 5. Viscosity vs. frequency curves at 35 °C for the three formulations 
listed in Table 2
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skin burn wound treatment. The addition of hyaluronic acid led to no 
significant change in the Tsol–gel in relation to the binary water/poloxa-
mer formulation. However, the addition of polymeric microparticles 
caused a slight reduction in the Tsol–gel without a significant reduction 
in the gel strength and providing a Tsol–gel value that still lies within 
the range of interest. The behavior of the P18/HA/MP formulation 
with respect to the dynamic moduli, pseudoplastic characteristics, and 
viscosity values at low and high frequency limits indicates that this 
system is rheologically suitable for application as a thermosensitive 
hydrogel for the treatment of burn wounds.
SUPPLEMENTARY MATERIAL
The IR spectra are located at http://quimicanova.sbq.org.br in a 
pdf file, with free access.
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Figure 1S. IR spectra of alpha-tocopherol, alpha tocopherol acetate, Aloe vera, the microparticles, and the poloxamer
